Характеристика лекарственно-индуцированных кожных реакций в многопрофильном скоропомощном стационаре

This prospective study was carried out in a period of 1 year on the basis of the multifield emergency hospital in the departments of therapy, urology and purulent surgery. On the basis of data of the screening method and the method of spontaneous messages a group of 347 patients with skin reactions, which potentially associated with the intake of medicines was highlighted in. Among them, there were 179 patients with non drug associated skin reactions and 168 patients with drug-induced skin reactions. The most common cutaneous drug reactions (CDR) were: acute urticaria, angioedema; drug toxidermia; allergic dermatitis; hemorrhagic vasculitis. Mostly СDR were caused by the following groups of drugs: b-lactam antibiotics; fluoroquinolones; drugs, improving cerebral blood flow; rentgencontrasting substances.Настоящее проспективное исследование осуществлялось в течение 1 года на базе многопрофильного скоропомощного стационара в отделениях терапии, урологии и гнойной хирургии. На основании данных скринингового метода и метода спонтанных сообщений была выделена группа пациентов количеством 347 человек с кожными реакциями, потенциально связанными с приемом лекарственных средств. Среди них было 179 пациентов c кожными реакциями, не связанными с приемом лекарственных средств (ЛС) и 168 пациентов с лекарственно-индуцированными кожными реакциями. Наиболее распространенными кожными лекарственными реакциями (КЛР) были: острая крапивница, отек Квинке; лекарственные токсидермии; аллергические дерматиты; геморрагические васкулиты. Чаще всего КЛР вызывали следующие группы ЛС: b-лактамные антибиотики; фторхинолоны; ЛС, улучшающие мозговой кровоток; рентгеноконтрастные вещества

Effects of fluvastatin, valsartan, and their combination on endothelial function in patients with arterial hypertension and dyslipidemia

Aim. To study the effects of an angiotensin II receptor antagonist (ARA II) valsartan, a statin (fluvastatin XL), and their combination on endothelial function (EF) in patients with arterial hypertension (AH) and dyslipidemia (DLP). Material and methods. In total, 30 patients with untreated, non-complicated Stage I-II AH and DLP IIA or IIB were randomised for 8-week monotherapy with valsartan or fluvastatin XL, with the subsequent addition of the second component, fluvastatin XL or valsartan, respectively. Results. Valsartan monotherapy was associated with a reduced increase in linear blood flow velocity (LFV) during the reactive hyperemia test (RHT) - 177,7 +/- 5,8 vs. 170,0 +/- 4,9% (p0,05). Eight-week monotherapy with fluvastatin XL (80 mg/d) was linked to moderate but statistically significant reduction (-2%) in systolic blood pressure (SBP), with no effect on diastolic BP level. In RHT, LFV increase did not change, but EF improved, as manifested in BA EDVD increase. Prolonged combined therapy resulted in further EF improvement. Conclusion. Combined fluvastatin XL and valsartan therapy in patients with untreated Stage I-II AH and DLP IIA or IIB improved EF more effectively than valsartan or fluvastatin XL monotherapy

Acute coronary syndrome due to coronary vasospasm - Case report

Spasm of the coronary arteries is a dynamic narrowing of one or more coronary arteries, leading to significant restriction of the lumen. The leading role in coronary artery spasm diagnostic belongs to coronary angiography and its accompanying provocative tests. Mechanisms of coronary artery spasm development remain incompletely clarified and it's considered as a multifactorial disease with its own specific risk factors. Though pathophysiology is no longer a matter of dispute, further efforts should be aimed at the practical application of the recommendations. Diagnosis of the coronary artery spasm has important practical significance, due to the prevailing benefit of calcium antagonists in the treatment and absence of benefit from percutaneous coronary interventions in most cases. A clinical case of the patient with multivessel, multifocal coronary artery spasm is presented